Depression and Anxiety Trial, Recruiting NCT04621877 Sponsor: University of Washington Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT04621877
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has three different groups of participants. Here are the criteria for each:

As a Client Participant (person receiving support):

  • People aged 60 years or older
  • People who attend one of the 18 participating senior centres in Seattle, New York City, or Tampa
  • People who score 10 or higher on a standard depression screening questionnaire (PHQ-9) during routine screening
  • People whose depression is confirmed as moderate-to-severe through a clinical interview (HAM-D score above 14)
  • People who score within the normal range on a standard memory and thinking assessment (confirm with trial site for exact score thresholds)
  • People who are either not currently taking antidepressant medication, or who have been on a stable antidepressant dose for at least 12 weeks
  • People who are able to give written consent to take part in both the research assessment and the support programme

As a Volunteer Participant:

  • People aged 60 years or older
  • People who attend one of the participating senior centres in Seattle, New York City, or Tampa

As a Clinician Participant:

  • People who hold a Master's degree in social work, counselling, marriage and family therapy, or another clinical mental health field
  • People who speak English or Spanish
  • People who are able to give consent for all parts of the study
  • People who are willing to have their sessions audio recorded for supervision and evaluation purposes

Who may not be able to join:

Client Participants:

  • People who are currently experiencing active thoughts of suicide
  • People who have been diagnosed with a psychiatric condition other than non-psychotic major depression or generalised anxiety disorder (as confirmed through a structured clinical interview)
  • People with a severe or life-threatening medical illness, such as end-stage organ failure
  • People who are unable to speak English or Spanish

Volunteer Participants:

  • People who currently have major depressive disorder, alcohol or substance use issues, or symptoms of mania, hypomania, or psychosis (as confirmed through a structured clinical interview)
  • People whose scores on the memory and thinking assessment fall below the required threshold (confirm with trial site for exact details)
  • People who are unable to speak and read English or Spanish

Clinician Participants:

  • People who do not speak English or Spanish
  • People who do not hold a qualifying Master's degree in a clinical mental health field
  • People who are unable to provide consent
  • People who are unwilling to have sessions audio recorded

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Patrick J Raue, PhD, University of Washington

Phone: 206-616-2129

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
27 January 2021
Est. completion
30 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hamilton Rating Scale for Depression (HAM-D); Behavioral Activation Scale (BADS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov